NeuroPace (NASDAQ:NPCE) Given New $18.00 Price Target at Cantor Fitzgerald
NeuroPace (NASDAQ:NPCE – Free Report) had its price target upped by Cantor Fitzgerald from $16.00 to $18.00 in a report released on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Other analysts have also recently issued research reports about the company. JPMorgan Chase & Co. boosted their target price […]
9 Mar 10:22 · The Markets Daily